---
title: "EU-GMP Readiness and Supply Chain Strategies for Chinese Pharma"
description: "A practical guide for Chinese manufacturers preparing for EU market access. Request the recording to learn how EU-GMP requirements, inspections, and supply chain design impact registration timelines and launch readiness."
url: https://qbdgroup.com/en/webinars/eu-gmp-readiness-supply-chain-strategies-chinese-pharma
type: "Webinar"
language: en
published: 2026-05-08
author: "Marta Klepczyńska & Joanna Rapacz"
category: "Pharma & Biotech"
publisher: "QbD Group"
citation: "QbD Group, \"EU-GMP Readiness and Supply Chain Strategies for Chinese Pharma\", https://qbdgroup.com/en/webinars/eu-gmp-readiness-supply-chain-strategies-chinese-pharma"
---
# EU-GMP Readiness and Supply Chain Strategies for Chinese Pharma
> A practical guide for Chinese manufacturers preparing for EU market access. Request the recording to learn how EU-GMP requirements, inspections, and supply chain design impact registration timelines and launch readiness.

## About this webinar

For Chinese pharmaceutical companies with a strong focus on **manufacturing**, entering Europe requires more than regulatory approval. It demands **end-to-end GMP and supply chain readiness**, from API and finished product manufacturing to **testing, batch certification, and distribution** in the EU.

This webinar is designed as a **practical guide for manufacturers preparing for Europe**. It explains how **EU-GMP requirements** apply across the manufacturing and supply chain lifecycle, how **inspections and certifications** influence timelines, and how to build a **launch-ready setup** that supports smooth **QP release** and uninterrupted supply. The session combines regulatory expectations with operational realities, helping manufacturers translate EU requirements into actionable steps.

## What you'll learn

- How **EU-GMP requirements** impact Chinese manufacturing sites and how GMP readiness influences EU registration and approval timelines
- What **European inspectors and QPs** expect from manufacturers, including documentation, audits, **QP Declarations**, and supplier oversight
- How to prepare **manufacturing sites and quality systems** to support EU inspections without disrupting ongoing production
- How to design a **compliant EU supply chain**, including testing, warehousing, **serialization**, and distribution, aligned with manufacturing capabilities
- How early planning for **batch certification and QP release** can prevent delays at launch
- **Practical examples** of how manufacturers have successfully aligned production and supply chain operations for EU market access

## Speakers

This session brings together regulatory, CMC, and Qualified Person expertise to help Chinese manufacturers navigate **EU-GMP readiness, batch certification, and supply chain design** for the European market.

### Joanna Popiołkiewicz, PharmD
**Scientific and Business Development Director, QPPV at QbD Group**

Joanna has 20 years of experience in drug development consulting, covering regulatory strategy oversight, preclinical and clinical development, and pharmacovigilance services. She holds an MSc and PhD in pharmacy with academic specialization in clinical analytics and molecular biology, and is the author of numerous scientific publications on biomedical research. Before joining QbD Group, she gained experience at the National Medicines Institute and Novartis in Clinical Trials.

### Marta Klepczynska
**Head of CMC Department & Qualified Person at QbD Group**

Marta holds a master's degree in chemistry with postgraduate studies in industrial pharmacy and has 15 years of experience in quality assurance, GMP/GLP audits, and CMC process management. She began her career in quality control at Adamed Pharma before taking on leadership roles. As Head of the CMC Department and Qualified Person at QbD Group, she oversees CMC compliance and drives the development and release of pharmaceutical products.

### Joanna Rapacz
**CMC and RA Director & Qualified Person at QbD Group**

Joanna has over 25 years of experience in the pharmaceutical industry, covering regulatory affairs, CMC strategy, GMP quality oversight, and implementation. She holds a master's degree in chemistry and has built her expertise across quality control, R&D, and regulatory compliance at leading pharmaceutical companies and institutes.

## Who Should Attend

This webinar is built for teams driving EU market access from China-based manufacturing operations.

- **Manufacturing and site leaders** at Chinese pharmaceutical companies planning EU market access
- **Quality Assurance (QA) professionals** responsible for GMP compliance, audits, and quality systems
- **Quality Control (QC) managers** involved in EU testing, method transfer, and release activities
- **Supply chain and technical operations teams** coordinating testing, warehousing, distribution, and serialization
- Professionals involved in **EU QP coordination and batch certification**
---
Source: https://qbdgroup.com/en/webinars/eu-gmp-readiness-supply-chain-strategies-chinese-pharma — © QbD Group. Quote freely with attribution and a link back.